GlobalData on MSN1d
Phoenix Molecular kicks off Phase II part of breast cancer combo trial
The Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...
Cancer Therapy Advisor1d
FDA Allows Use of Recombinant BCG Through Expanded Access Program
The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
lupusnewstoday2d
FDA grants ADI-001 fast track status for treatment-resistant SLE
The U.S. Food and Drug Administration (FDA) has granted fast track status to ADI-001, Adicet Bio ’s CAR T-cell therapy for ...
rheumatologyadvisor2d
FDA Grants Fast Track Status to PP-01 for Cannabis Withdrawal Syndrome
The FDA has granted Fast Track designation to PP-01 for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.